학술논문
Predictive value of interim F-18-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
01433636